Affiliation: Erasmus University
Country: The Netherlands
- Cost-effectiveness of two endovascular treatment strategies vs intravenous thrombolysisJ C Bouvy
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, The Netherlands
Acta Neurol Scand 127:351-9. 2013..To assess the cost-effectiveness of endovascular treatment against intravenous thrombolysis (IVT) when varying assumptions concerning its effectiveness...
- The cost-effectiveness of periodic safety update reports for biologicals in EuropeJ C Bouvy
Utrecht Institute for Pharmaceutical Sciences UIPS, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands
Clin Pharmacol Ther 93:433-42. 2013..It is possible to assess the cost-effectiveness of regulatory requirements using the same methods as those used in assessing the cost-effectiveness of medical interventions...
- The cost-effectiveness of drug regulation: the example of thorough QT/QTc studiesJ C Bouvy
Institute for Medical Technology Assessment, Faculty of Health, Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands
Clin Pharmacol Ther 91:281-8. 2012..Our study shows that cost-effectiveness analysis of drug regulatory measures is feasible and should be considered before developing such measures...
- Willingness to pay for adverse drug event regulatory actionsJacoline Bouvy
Institute for Medical Technology Assessment, Department of Health Policy and Management iBMG, Erasmus University Rotterdam, Rotterdam, The Netherlands
Pharmacoeconomics 29:963-75. 2011..Regulatory requirements for the pharmaceutical industry have become increasingly demanding with respect to the safety and effectiveness of drugs...